12/19/2024
11:15 PM | Chromocell Therapeutics (Filer)
| Form EFFECT | |
12/11/2024
3:06 PM | Chromocell Therapeutics (Filer)
| Form POS AM | |
12/02/2024
11:15 PM | Chromocell Therapeutics (Filer)
| Form EFFECT | |
11/22/2024
3:30 PM | Chromocell Therapeutics (Filer)
| Form POS AM | |
11/21/2024
8:00 AM | Chromocell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
4:03 PM | Chromocell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
3:19 PM | Chromocell Therapeutics (Issuer)
Friedberg Ezra M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
11/15/2024
3:20 PM | Chromocell Therapeutics (Issuer)
Malamut Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
3:22 PM | Chromocell Therapeutics (Issuer)
Davis Todd C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
4:19 PM | Chromocell Therapeutics (Filer)
| Form 424B3 | |
11/13/2024
4:14 PM | Chromocell Therapeutics (Filer)
| Form 424B3 | |
11/13/2024
3:30 PM | Chromocell Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024
3:05 PM | 3i, LP (Filed by)
Chromocell Therapeutics (Subject)
| Form SC 13G/A | |
10/24/2024
7:30 AM | Chromocell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2024
4:08 PM | Chromocell Therapeutics (Filer)
| Form DEF 14A | |
09/16/2024
3:55 PM | Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
3:56 PM | Chromocell Therapeutics (Issuer)
Malamut Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
4:35 PM | Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
4:30 PM | Chromocell Therapeutics (Filer)
| Form PRE 14A | |
08/13/2024
4:23 PM | Chromocell Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
4:19 PM | Chromocell Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
3:31 PM | Chromocell Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2024
3:50 PM | Chromocell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
11:15 PM | Chromocell Therapeutics (Filer)
| Form EFFECT | |
08/06/2024
3:49 PM | Chromocell Therapeutics (Filer)
| Form 424B3 | |
07/29/2024
8:06 AM | Chromocell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/29/2024
8:07 AM | Chromocell Therapeutics (Filer)
| Form 424B3 | |
07/29/2024
8:08 AM | Chromocell Therapeutics (Filer)
| Form 424B3 | |
07/29/2024
8:15 AM | Chromocell Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
07/02/2024
4:15 PM | Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
| Form 3/A | |
07/02/2024
4:17 PM | Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
7:05 PM | Chromocell Therapeutics (Issuer)
Lang Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
7:06 PM | Chromocell Therapeutics (Issuer)
Simmons Chia-Lin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
7:07 PM | Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
| Form 4/A | |
06/18/2024
7:00 PM | Chromocell Therapeutics (Issuer)
Davis Todd C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
7:01 PM | Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
7:02 PM | Chromocell Therapeutics (Issuer)
Malamut Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
7:03 PM | Chromocell Therapeutics (Issuer)
Friedberg Ezra M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
3:21 PM | Chromocell Therapeutics (Filer)
| Form 424B3 | |
05/15/2024
3:15 PM | Chromocell Therapeutics (Filer)
| Form 424B3 | |
04/16/2024
3:48 PM | Chromocell Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad) Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days.
It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year.
This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now |
04/12/2024
6:22 PM | Chromocell Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
04/09/2024
7:30 AM | Chromocell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
8:00 AM | Chromocell Therapeutics (Filer)
| Form NT 10-K | |
03/21/2024
8:00 AM | Chromocell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
7:00 AM | Chromocell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
4:10 PM | Chromocell Therapeutics (Subject)
Motif Pharmaceuticals Ltd. (Filed by)
| Form SC 13G | |
03/01/2024
4:13 PM | AME Equities LLC (Filed by)
Chromocell Therapeutics (Subject)
| Form SC 13G | |
03/01/2024
4:16 PM | Aperture Healthcare Ventures Ltd. (Filed by)
Chromocell Therapeutics (Subject)
| Form SC 13G | |
03/01/2024
4:19 PM | Benuvia Operations, LLC (Filed by)
Chromocell Therapeutics (Subject)
| Form SC 13G | |
02/26/2024
5:36 PM | Chromocell Therapeutics (Subject)
Friedberg Ezra M (Filed by)
| Form SC 13D | |
02/23/2024
4:12 PM | Chromocell Therapeutics (Issuer)
Friedberg Ezra M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:15 PM | Chromocell Therapeutics (Issuer)
Davis Todd C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:17 PM | Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
4:28 PM | Chromocell Therapeutics (Filer)
| Form 424B4 | |
02/20/2024
4:30 PM | Chromocell Therapeutics (Filer)
| Form 424B4 | |
02/15/2024
8:56 PM | Chromocell Therapeutics (Filer)
| Form POS EX | |
02/15/2024
7:33 PM | Aperture Healthcare Ventures Ltd. (Reporting)
Chromocell Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/15/2024
7:36 PM | Chromocell Therapeutics (Issuer)
Motif Pharmaceuticals Ltd. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/15/2024
7:38 PM | Boswell Prayer Ltd. (Reporting)
Chromocell Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/15/2024
7:25 PM | AME Equities LLC (Reporting)
Chromocell Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/15/2024
7:31 PM | Chromocell Therapeutics (Issuer)
Simmons Chia-Lin (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/15/2024
7:02 PM | Chromocell Therapeutics (Issuer)
Davis Todd C (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/15/2024
7:06 PM | Balmoral Financial Group LLC (Reporting)
Chromocell Therapeutics (Issuer)
Friedberg Ezra M (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/15/2024
7:10 PM | Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/15/2024
7:12 PM | Chromocell Therapeutics (Issuer)
Lang Eric (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/15/2024
7:14 PM | Chromocell Therapeutics (Issuer)
Malamut Richard (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/15/2024
10:46 AM | Chromocell Therapeutics (Filer)
| Form CERT | |
02/15/2024
10:35 AM | Chromocell Therapeutics (Filer)
| Form 8-A12B | |
02/14/2024
11:15 PM | Chromocell Therapeutics (Filer)
| Form EFFECT | |
02/12/2024
7:09 AM | Chromocell Therapeutics (Subject)
| Form FWP | |
02/12/2024
7:02 AM | Chromocell Therapeutics (Filer)
| Form S-1/A | |
02/06/2024
7:40 PM | Chromocell Therapeutics (Filer)
| Form S-1/A | |
02/06/2024
7:43 PM | Chromocell Therapeutics (Subject)
| Form FWP | |
01/16/2024
4:28 PM | Chromocell Therapeutics (Filer)
| Form S-1/A | |
